Skip to main content
  • Saved

made a Post

Close to 25% of migraine patients don’t respond to triptans. Many have contraindications (coronary disease, etc.) to triptans or to their alternatives (such as NSAIDs in patients on anticoagulation, etc.)... So, I’m very excited for the NEW migraine abortive gepant class with Ubrelvy (Ubrogepant)! This is a calcitonin gene-related peptide (CGRP) receptor antagonist. It is not a migraine preventative monoclonal CGRP antibody treatment such as Aimovig, Ajovy, or Emgality. It is indicated for the acute treatment of migraine with or without aura in adults. Patients can get it for $10 a month, which is great way for them to be able to trial it. Most pharmacies are now carrying it.

UBRELVY™ (ubrogepant) - Acute Treatment for Migraine | Allergan

Source : https://www.ubrelvy.com/home

This website uses cookies and other technologies to personalize content and to show you more personalized ads (for example, Google Ads and Facebook) on this and other websites, as well as provide you with social media features on this website (such as, Facebook, Twitter, LinkedIn).

Sign In or Register Today to Access This Content